Sue Molina V.

Director, Sucampo Pharmaceuticals.

Companies

Adeia Inc.Board member Oct 12, 2022 to now¹
Xperi CorporationBoard member Feb 8, 2018 to Jun 3, 2020²
DTS, Inc.Board member Jan 8, 2008 to Dec 5, 2016³
Sucampo PharmaceuticalsBoard member Aug 2, 2007 to Aug 2, 2007⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Adeia Inc. ADEA79,534 shares⁵$1.7M at $20.91May 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

May 7, 2026Granted 6,930 shares of Adeia Inc.⁵
May 8, 2025Granted 14,060 shares of Adeia Inc.⁶
May 9, 2024Granted 16,920 shares of Adeia Inc.⁷
May 25, 2023Granted 20,320 shares of Adeia Inc.⁸
Oct 3, 2022Granted 15,415 shares of Adeia Inc.⁹
Oct 3, 2022Granted 15,415 shares of Adeia Inc.¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAdeia Inc., Board member
2
SEC EDGARXperi Corporation, Board member
3
SEC EDGARDTS, Inc., Board member
4
SEC EDGARSucampo Pharmaceuticals, Board member
5
SEC EDGARAdeia Inc. shares after the filing of May 7, 2026
6
SEC EDGARForm 4 filed May 9, 2025
7
SEC EDGARForm 4 filed May 10, 2024
8
SEC EDGARForm 4 filed May 26, 2023
9
SEC EDGARForm 4 filed Oct 12, 2022
10
SEC EDGARForm 4 filed Apr 14, 2023